Literature DB >> 16877807

Single nucleotide polymorphisms in the RET gene and their correlations with Hirschsprung disease phenotype.

Robert Smigiel1, Arleta Lebioda, Dariusz Patkowski, Jerzy Czernik, Tadeusz Dobosz, Karolina Pesz, Monika Kaczmarz, Maria M Sasiadek.   

Abstract

Hirschsprung disease (HSCR) is a congenital, heterogeneous disorder, characterized by the absence of intestinal ganglion cells. Recent advances show that the RET gene is a major locus involved in the pathogenesis of HSCR. The aim of this study was to analyse if the HSCR phenotype in the Polish population is associated with the presence of polymorphisms in exons 2, 3, 7, 11, 13, 14 and 15 of the RET gene. Molecular results were compared with clinical and long-term follow-up data in 70 Polish patients with HSCR (84.3% with a short segment and 15.7% with a long segment of aganglionic gut). Single-nucleotide polymorphisms were analysed by using the minisequencing SNaPshot multiplex method. The 135G>A polymorphism in RET exon 2 was overrepresented in HSCR patients, compared with a healthy control group. Moreover, the 135G>A variant was shown to be associated with the severe HSCR phenotype. Two other polymorphisms, 2071G>A in exon 11 and 2712C>G in exon 15, were underrepresented in the patients. The results confirm that these RET polymorphisms play a role in the aetiology of HSCR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16877807     DOI: 10.1007/bf03194634

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  18 in total

1.  Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression.

Authors:  S Borrego; M E Sáez; A Ruiz; O Gimm; M López-Alonso; G Antiñolo; C Eng
Journal:  J Med Genet       Date:  1999-10       Impact factor: 6.318

2.  RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease.

Authors:  S Borrego; A Ruiz; M E Saez; O Gimm; X Gao; M López-Alonso; A Hernández; F A Wright; G Antiñolo; C Eng
Journal:  J Med Genet       Date:  2000-08       Impact factor: 6.318

3.  Association between c135G/A genotype and RET proto-oncogene germline mutations and phenotype of Hirschsprung's disease.

Authors:  Guido Fitze; Jakob Cramer; Andreas Ziegler; Mandy Schierz; Matthias Schreiber; Eberhard Kuhlisch; Dietmar Roesner; Hans K Schackert
Journal:  Lancet       Date:  2002-04-06       Impact factor: 79.321

4.  Segregation at three loci explains familial and population risk in Hirschsprung disease.

Authors:  Stacey B Gabriel; Rémi Salomon; Anna Pelet; Misha Angrist; Jeanne Amiel; Myriam Fornage; Tania Attié-Bitach; Jane M Olson; Robert Hofstra; Charles Buys; Julie Steffann; Arnold Munnich; Stanislas Lyonnet; Aravinda Chakravarti
Journal:  Nat Genet       Date:  2002-04-15       Impact factor: 38.330

5.  Dissecting Hirschsprung disease.

Authors:  Eberhard Passarge
Journal:  Nat Genet       Date:  2002-04-15       Impact factor: 38.330

6.  Incidence of RET mutations in patients with Hirschsprung's disease.

Authors:  M Sancandi; I Ceccherini; M Costa; M Fava; B Chen; Y Wu; R Hofstra; T Laurie; M Griffths; D Burge; P K Tam
Journal:  J Pediatr Surg       Date:  2000-01       Impact factor: 2.545

Review 7.  [The role of ret gene in the pathogenesis of Hirschsprung disease].

Authors:  Robert Smigiel; Dariusz Patkowski; Ryszard Slezak; Jerzy Czernik; Maria Sasiadek
Journal:  Med Wieku Rozwoj       Date:  2004 Jul-Sep

Review 8.  Hirschsprung's disease: a search for etiology.

Authors:  P Puri; K Ohshiro; T Wester
Journal:  Semin Pediatr Surg       Date:  1998-08       Impact factor: 2.754

9.  Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease.

Authors:  T Attié; A Pelet; P Edery; C Eng; L M Mulligan; J Amiel; L Boutrand; C Beldjord; C Nihoul-Fékété; A Munnich
Journal:  Hum Mol Genet       Date:  1995-08       Impact factor: 6.150

10.  Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease.

Authors:  G Romeo; P Ronchetto; Y Luo; V Barone; M Seri; I Ceccherini; B Pasini; R Bocciardi; M Lerone; H Kääriäinen
Journal:  Nature       Date:  1994-01-27       Impact factor: 49.962

View more
  1 in total

1.  RET and PHOX2B genetic polymorphisms and Hirschsprung's disease susceptibility: a meta-analysis.

Authors:  Chun-mei Liang; Dong-mei Ji; Xu Yuan; Ling-ling Ren; Juan Shen; Hai-yan Zhang
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.